Clinical Trials Browser

Phase NA × INDUSTRY × Low Risk Prostate Cancer × Clear all

NCT03740191 2025-05-11

Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer

Phase NA Terminated

Low Risk Prostate Cancer